Vnitr Lek 2020, 66(5):314-315 | DOI: 10.36290/vnl.2020.087

Treatement of dyspnea: the cause of troublesome diagnostic process of neurological illness

MUDr. Michal Scheinost1, MUDr. Michaela Martincová1, MUDr. Zuzana Podhrázská1, MUDr. Andrej Mokeev1, MUDr. Martin Forgáč2
1 Interní oddělení Nemocnice Neratovice, Almeda, a. s.
2 Neurologické centrum Praha Vinoř, s. r. o.

This casuistic talks about the patient who was admitted to hospital for acute bronchitis. Treatment of respiratory illness led to exacerbation of latent myasthenia gravis (MG). Difficulties in diagnostics of MG were caused by atypical form of illness and also by treatment of bronchitis which modified classical symptoms.

Keywords: dyspnea, myasthenia gravis, macrolide antibiotics, corticosteroids.

Published: August 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Scheinost M, Martincová M, Podhrázská Z, Mokeev A, Forgáč M. Treatement of dyspnea: the cause of troublesome diagnostic process of neurological illness. Vnitr Lek. 2020;66(5):314-315. doi: 10.36290/vnl.2020.087.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Heldal AT, Eide GE, Gilhus NE, Romi F. Geographical distribution of a seropositive myasthenia gravis population. Muscle Nerve 2012; 45: 815. Go to original source... Go to PubMed...
    2. Oosterhuis HJ. The natural course of myasthenia gravis: a long term follow up study. J Neurol Neurosurg Psychiatry 1989; 52: 1121. Go to original source... Go to PubMed...
    3. Mantegazza R, Beghi E, Pareyson D, et al. A multicentre follow‑up study of 1152 patients with myasthenia gravis in Italy. J Neurol 1990; 237: 339. Go to original source... Go to PubMed...
    4. Herishanu Y, Taustein I. The electromyographic changes induced by antibiotics: a preliminary study. Confin Neurol. 1971; 33(1): 41-45. doi: 10.1159/000103101. Go to original source...
    5. Cadisch R, Streit E, Hartmann K. Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax) [in German]. Schweiz Med Wochenschr.1996; 126(8): 308-310. Go to PubMed...
    6. Schneider‑Gold C, Gajdos P, Toyka KV, Hohlfeld RR. Corticosteroids for myasthenia gravis. Cochrane Database Syst Rev. 2005 Apr 18; (2): CD002828. Go to original source... Go to PubMed...
    7. Pal S, Sanyal D. Jaw muscle weakness: a differential indicator of neuromuscular weakness-preliminary observations. Muscle Nerve 2011; 43: 807. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.